SPINRAZA US Consumer and HCP campaign

SMA (Spinal Muscular Atrophy) is a rare neuromuscular disorder often affecting children at a very young age. Spinraza is the first and only medication to treat this order and boost the development of muscular movements. This campaign is both consumer (caregiver) and HCP facing and expresses the possibility of children with SMA reaching key motor milestones and being able to live their lives.